With Douglas Elliman (NYSE: DOUG) going ex- dividend is there a room to get bullish on housing ?

With Douglas Elliman (NYSE: DOUG) going ex- dividend is there a room to get bullish on housing ?

ByMarketFacts

Douglas Elliman Inc. (XYNS: DOUG) is a real estate company. Among other real estate-related services, it provides sales, rentals, and new development in combination with mortgages and title insurance. The company operates in two divisions: Real Estate Brokerage and Corporate and Other. The company makes revenue from Commission and other brokerage income from existing house sales, Commission and other brokerage income from development marketing, Property management income, and Title fees. 

How to survive bear market ?

How to survive bear market ?

ByMarketFacts

As reflected in the Standard & Poor’s 500 and the Nasdaq Composite Index, a Bear Market is commonly defined as a stock market decline of 20% or more from its recent highs. Factors such as weak or declining economy, pandemics, wars, interest rate hikes, oil price movements, bursting market bubbles and unexpected high inflation figures can all contribute to a bear market.  

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

ByMarketFacts

Protagonist Therapeutics, Inc.(XNAS:PGTX) is a biopharmaceutical company that discovers and develops peptide based therapeutic drugs to address hematology and blood disorders, as well as inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 antagonist peptide, which is currently in Phase II clinical trials for the treatment of inflammatory bowel disease (IBD); and PN-235, an interleukin-23 receptor antagonist for the treatment of both IBD and non-IBD indications. A license and collaboration agreement has been signed between the company and Janssen Biotech Inc.

Is this solar energy stock worthy enough to be in your portfolio: Sunrun Inc.(NASDAQ: RUN)?

Is this solar energy stock worthy enough to be in your portfolio: Sunrun Inc.(NASDAQ: RUN)?

ByMarketFacts

Sunrun Inc. (XNAS: RUN) is an American provider of photovoltaic solar energy generation systems and battery energy storage products, primarily for residential customers. The company was established in 2007 and is headquartered in San Francisco, California. Sunrun Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company markets and sells its products through direct-to-consumer approach across online, retail, mass media as well as its partner network. The company installs solar energy systems on its customers’ homes and provides them with the solar power produced by those systems for a 20- or 25-year initial term. It monitors, maintains, and ensures the system during the term of the contract.

Should you buy the dip now as growth resumes in Alteryx Inc (NYSE: AYX)?

Should you buy the dip now as growth resumes in Alteryx Inc (NYSE: AYX)?

ByMarketFacts

Alteryx Inc. (NYSE: AYX) is a software company that offers self-service data analytics software. By using its software platform, businesses may boost business results and business analyst productivity by significant margins. The company provides a wide range of services, including advanced analytics, location intelligence, data preparation, technological integrations, and more. Its customer base includes businesses in the financial, healthcare, retail, logistics, oil & gas, pharmaceutical, and biotech sectors. The primary source of income for the business is the licensing of its software platform to users on a subscription basis.

Top 5 Healthcare Stocks Expected To Thrive Post Pandemic

Top 5 Healthcare Stocks Expected To Thrive Post Pandemic

ByMarketFacts

Healthcare has become one of the world’s largest sector, both in terms of revenue and employment. It comprises of hospitals, medical devices, equipment, insurance, medicines, and vaccines. The US healthcare industry is massive, with healthcare spending accounting for over 19.7% of US GDP in 2020. As a result, the healthcare sector in US is seeing strong and sustained growth.
Since the demand for healthcare products is ever increasing, the sector provides steady and consistent returns that are uncorrelated with the overall direction of the stock market. Here are the top 5 healthcare stocks to look out for.

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

Shall Investors punt on this pharmaceutical penny stock: Avenue Therapeutics Inc. (NASDAQ: ATXI)?

ByMarketFacts

Avenue Therapeutics (XNAS: ATXI) is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. Its mission is to develop IV tramadol, a potential alternative that could reduce the use of conventional opioids, for patients suffering from acute pain in the U.S. Avenue is headquartered in New York City and was founded by Fortress Biotech, Inc. Fortress is focused on acquiring, developing and commercializing high-potential marketed and development-stage drugs and drug candidates.

Is Bandwidth Inc.(NASDAQ: BAND) a good buy after an 80% decline?

Is Bandwidth Inc.(NASDAQ: BAND) a good buy after an 80% decline?

ByMarketFacts

Bandwidth Inc. (NASDAQ: BAND) is a global communications software company that helps enterprises connect people around the world with cloud-ready voice, messaging and emergency services. Backed by a network reaching 60+ countries covering 90 percent of global GDP, companies like Cisco, Google, Microsoft, RingCentral, Uber and Zoom use Bandwidth’s APIs to easily embed communications into software and applications. Bandwidth has more than 20 years in the technology space and was the first Communications Platform-as-a-Service (CPaaS) provider offering a robust selection of APIs built on the own global network.

Will Plug power up your portfolio?
|

Will Plug power up your portfolio?

ByMarketFacts

Plug Power Inc. (NASDAQ:PLUG) is an American company engaged in the development of hydrogen fuel cell systems that replace conventional batteries in equipment and vehicles powered by electricity. As the leading provider of comprehensive hydrogen fuel cell (HFC) turnkey solutions, Plug is constructing the hydrogen economy. In the midst of a persistent paradigm shift in the power, energy, and transportation sectors to address climate change and energy security, while delivering efficiency benefits and meeting sustainability targets, the company’s breakthrough technology powers electric motors using hydrogen fuel cells. The company is the largest purchaser of liquid hydrogen and has installed more than 50,000 fuel cell units and over 165 fuelling stations, more than any other company in the world, to establish the first commercially viable market for hydrogen fuel cell technology.

Can Purple Innovation Inc Make your portfolio green (NASDAQ: PRPL) ?

Can Purple Innovation Inc Make your portfolio green (NASDAQ: PRPL) ?

ByMarketFacts

Purple Innovation Inc. (NASDAQ: PRPL) is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, pillows, cushions, sheets, bed platforms, and other products. Its proprietary gel technology, Hyper-Elastic Polymer, underpins many of the comfort products and provides a range of benefits that differentiate the offerings from other competitors’ products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.